SI
SI
discoversearch

We've detected that you're using an ad content blocking browser plug-in or feature. Ads provide a critical source of revenue to the continued operation of Silicon Investor.  We ask that you disable ad blocking while on Silicon Investor in the best interests of our community.  If you are not using an ad blocker but are still receiving this message, make sure your browser's tracking protection is set to the 'standard' level.
Biotech / Medical : Biotech & Pharma.T.A, -- Ignore unavailable to you. Want to Upgrade?


To: Jibacoa who wrote (2064)1/10/2008 10:42:14 AM
From: Jibacoa  Read Replies (1) | Respond to of 3722
 
KOOL started a little UM yesterday & today opened with an UG & is still up 16.57%

bigcharts.marketwatch.com

I announced today that it expects revenues for the 2ndQ to be in the range of $5.3-$5.5M, which would compare favorably with the $3.7M in 2007 and $3.6M in the 1stQ.

That will comply with its previous guidance of better sequential revenues. It said that it had better AXP bag set shipments, improved the BioArchive System sales & CryoSeal System and disposable sales.

They expect to have their second supplier of the AXP bag sets on line to full production capacity this quarter.

Discussions with GE Healthcare continue regarding the BioArchive distribution program & they expect to resolve the concerns with GE's overall sales effort.

In 2008 they expect continued sequential quarterly revenue growth through, a full AXP production ramp up & strong BioArchive sales,& quarterly revenues to climb above $7M in its 4thQ, reconfirming the prior guidance.

They mentioned that they have made progress in moving into regenerative medicine with a number of initiatives and expect to provide additional information in 2008.The results for the 2ndQ will be released on Feb6.(That will be before the Va primary on Feb12 <g>)

At any rate, KOOL has a good roster of institutional holders & the stock is trying to get off from the DT coming from its Nov2006 H at $5.06

finance.yahoo.com

It seems that the R/R isn't bad at present levels with a good chance for the stock to double in 2008, if we get some change in the general market's mood.

bigcharts.marketwatch.com

Bernard